0001415889-23-003199.txt : 20230223
0001415889-23-003199.hdr.sgml : 20230223
20230223165959
ACCESSION NUMBER: 0001415889-23-003199
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230221
FILED AS OF DATE: 20230223
DATE AS OF CHANGE: 20230223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zeldin Robert K
CENTRAL INDEX KEY: 0001745347
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38520
FILM NUMBER: 23660675
MAIL ADDRESS:
STREET 1: C/O ACCELERON PHARMA INC.
STREET 2: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MeiraGTx Holdings plc
CENTRAL INDEX KEY: 0001735438
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 EAST 29TH STREET
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 6464902965
MAIL ADDRESS:
STREET 1: 450 EAST 29TH STREET
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
4
1
form4-02232023_090215.xml
X0306
4
2023-02-21
0001735438
MeiraGTx Holdings plc
MGTX
0001745347
Zeldin Robert K
450 EAST 29TH STREET
14TH FLOOR
NEW YORK
NY
10016
false
true
false
false
CHIEF MEDICAL OFFICER
Stock Option (Right to Buy)
8.60
2023-02-21
4
A
0
30000
0
A
2033-02-21
Ordinary Shares
30000
30000
D
Restricted Share Units
2023-02-21
4
A
0
30000
0
A
Ordinary Shares
30000
30000
D
The option vests as to one quarter of the total grant on February 21, 2024 and vests as to the remainder in 36 equal monthly installments thereafter.
Each restricted share unit converts into one ordinary share upon vesting.
Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date.
/s/ Robert J. Wollin, Attorney-in-Fact for Robert K. Zeldin
2023-02-23